Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

33.32
Delayed Data
As of Jul 29
 -0.38 / -1.13%
Today’s Change
31.34
Today|||52-Week Range
39.95
-2.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues188.8M168.8M184.4M180.0M
 
 
 
 
 
Cost of Goods Sold25.5M32.0M31.8M29.9M
 
 
 
 
 
Depreciation And Amortization5.5M6.0M6.0M6.4M
 
 
 
 
 
 
Operating ExpensesGross Income157.8M130.9M146.5M143.7M
 
 
 
 
 
General Expenses104.5M105.0M110.2M108.0M
 
 
 
 
 
Research And Development20.2M22.6M17.5M16.7M
 
 
 
 
 
Total Operating Expenses135.5M142.9M148.1M144.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income53.3M25.9M36.3M35.7M
 
 
 
 
 
Other Expenses-908.0K-98.0K1.5M-298.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income52.6M25.9M37.9M35.6M
 
 
 
 
 
Income Taxes-18.9M-9.9M-13.9M-14.1M
 
 
 
 
 
Net Income33.6M16.0M24.0M21.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS74.4M72.8M72.5M70.7M
 
 
 
 
 
Shares To Calculate EPS Diluted77.7M76.1M75.4M73.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.43$0.21$0.32$0.29
 
 
 
 
 
EPS Diluted$0.43$0.21$0.32$0.29